TOCUITCONY
Trustees of Columbia University in the City of New York Portfolio holdings
AUM
$691M
This Quarter Return
+39.77%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$74.8M
AUM Growth
–
Cap. Flow
+$74.8M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
98.32%
Holding
13
New
13
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Kymera Therapeutics
KYMR
|
$28.7M |
| 2 |
Berkshire Hathaway Class A
BRK.A
|
$27.1M |
| 3 |
Generation Bio
GBIO
|
$8.87M |
| 4 |
Seres Therapeutics
MCRB
|
$1.47M |
| 5 |
RAPT Therapeutics
RAPT
|
$1.45M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 59.19% |
| 2 | Financials | 36.59% |
| 3 | Technology | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Kymera Therapeutics
KYMR
$2.95B
| $28.7M | 38.38% |
+463,298
| New | +$28.7M |
|
|
2
Berkshire Hathaway Class A
BRK.A
$1.09T
| $27.1M | 36.25% |
+78
| New | +$27.1M |
|
|
3
Generation Bio
GBIO
$40.4M
| $8.87M | 11.85% |
+312,876
| New | +$8.87M |
|
|
4
Seres Therapeutics
MCRB
$166M
| $1.47M | 1.96% |
+59,930
| New | +$1.47M |
|
|
5
RAPT Therapeutics
RAPT
$188M
| $1.45M | 1.94% |
+73,383
| New | +$1.45M |
|
|
EVLO
6
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $1.38M | 1.84% |
+113,850
| New | +$1.38M |
|
|
KLDO
7
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $1.37M | 1.83% |
+150,150
| New | +$1.37M |
|
8
Asana
ASAN
$3.44B
| $1.12M | 1.5% |
+37,970
| New | +$1.12M |
|
9
Progyny
PGNY
$2.04B
| $1.04M | 1.39% |
+24,597
| New | +$1.04M |
|
10
Microsoft
MSFT
$3.77T
| $1.04M | 1.39% |
+4,678
| New | +$1.04M |
|
11
Twilio
TWLO
$16.2B
| $912K | 1.22% |
+2,695
| New | +$912K |
|
|
12
Berkshire Hathaway Class B
BRK.B
$1.09T
| $256K | 0.34% |
+1,100
| New | +$256K |
|
13
Ribbon Communications
RBBN
$722M
| $86K | 0.11% |
+13,085
| New | +$86K |
|